[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636717":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":51,"collaborators":25,"id":53,"slug":25,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":25,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":25,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":76,"whyStopped":25,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Bedaya Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Successive doses GnRH agonist","EXPERIMENTAL","Three successive doses of GnRH agonist are administered 36 , 24 and 12 hours before oocyte retrieval",[13],"Drug: Successive doses GnRH agonist",{"label":15,"type":16,"description":17,"interventionNames":18},"Single dose GnRH agonist","ACTIVE_COMPARATOR","A single dose of GnRH agonist is administered 36 hours before oocyte retrieval",[19],"Drug: Single dose GnRH agonist",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","GnRH agonist ( Triptorelin ) ( 0.2 mg \u002F S.C ) is administered 36 hours before ovum pickup. Two additional doses of triptorelin ( 0.1 mg \u002F S.C ) are administered subcutaneously 12 and 24 hours after the first dose of GnRH agonist.",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"GnRH agonist ( Triptorelin ) ( 0.2 mg \u002F S.C ) is administered 36 hours before ovum pickup.",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Usama M. Fouda, Prof.","CONTACT","+201095401375","umfrfouda@yahoo.com",[36],{"facility":5,"status":25,"city":37,"state":25,"zip":25,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Giza","Egypt",{"type":40,"coordinates":41},"Point",[42,43],31.20861,30.00944,{"lat":43,"lon":42},[46,48],{"name":47,"role":32,"phone":25,"phoneExt":25,"email":34},"Usama M. Fouda, Prof",{"name":49,"role":50,"phone":25,"phoneExt":25,"email":25},"Ahmed Gadallah","PRINCIPAL_INVESTIGATOR",{"type":52,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100636717",false,"NCT07569315","Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders","Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders Undergoing IVF Cycle : A Randomized Controlled Study.","Inclusion Criteria:\n\n* GnRH antagonist IVF cycle\n* Hyper-responders to induction of ovulation\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion","FEMALE","18 Years","40 Years",{"count":63,"type":64},190,"ESTIMATED","INTERVENTIONAL",[67],"PHASE2","The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders",[70],"Infertility",[70,72,73,74,75],"GnRH agonist trigger","IVF-ET","Hyper-responders","PCOS","NOT_YET_RECRUITING","2026-05-06",{"date":79,"type":80},"2026-05-11","ACTUAL",{"date":82,"type":64},"2026-06-01",{"date":84,"type":64},"2028-04-01",{"name":5,"class":6},1]